1. 2821 The phase III study INTERCEPTOR in locally advanced head and neck cancer (LA-HNC). Preliminary safety report. (September 2015) Authors: Merlano, M.; Vecchio, S.; Bacigalupo, A.; Denaro, N.; Russi, E.; Benasso, M.; Vigo, V.; Ostellino, O.; Rampino, M.; Canobbio, L.; Grimaldi, A.; Blengio, F.; Berretta, L.; Bui, S.; D'Abbiero, N.; D'Amico, M.; Numico, G.; Bergamini, C.; Orlandi, E.; Aieta, M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S560 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2827 Role of induction chemotherapy in the multimodal management of locally advanced epithelial sinonasal cancer. (September 2015) Authors: Bossi, P.; Pala, L.; Orlandi, E.; Granata, R.; Battaglia, P.; Lombardi, D.; Guzzo, M.; Locati, L.; Barbára, M.; Quattrone, P.; Calareso, G.; Nicolai, P.; Castelnuovo, P.; Iacovelli, N.; Bergamini, C.; Resteghini, C.; Alfieri, S.; Imbimbo, M.; Licitra, L. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S567 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2865 Outcome of systemic treatments after first line platinum and cetuximab treatment in patients with recurrent/metastatic (RM) head and neck squamous cell cancer (HNSCC): A retrospective analysis. (September 2015) Authors: Siano, M.; Resteghini, C.; Cau, M.C.; Alfieri, S.; Bergamini, C.; Granata, R.; Miceli, R.; Infante, G.; Locati, L.; Licitra, L.; Bossi, P. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S578 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact. (December 2016) Authors: Locati, L.D.; Perrone, F.; Cortelazzi, B.; Bergamini, C.; Bossi, P.; Civelli, E.; Morosi, C.; Lo Vullo, S.; Imbimbo, M.; Quattrone, P.; Dagrada, G.P.; Granata, R.; Resteghini, C.; Mirabile, A.; Alfieri, S.; Orlandi, E.; Mariani, L.; Saibene, G.; Pilotti, S.; Licitra, L. Journal: European journal of cancer Issue: Volume 69(2016) Page Start: 158 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Adjuvant androgen deprivation therapy for poor-risk, androgen receptor–positive salivary duct carcinoma. (March 2019) Authors: van Boxtel, W.; Locati, L.D.; van Engen-van Grunsven, A.C.H.; Bergamini, C.; Jonker, M.A.; Fiets, E.; Cavalieri, S.; Tooten, S.; Bos, E.; Quattrone, P.; Verhaegh, G.W.; Schalken, J.A.; Licitra, L.; van Herpen, C.M.L. Journal: European journal of cancer Issue: Volume 110(2019) Page Start: 62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer. (July 2018) Authors: Cavalieri, S.; Perrone, F.; Miceli, R.; Ascierto, P.A.; Locati, L.D.; Bergamini, C.; Granata, R.; Alfieri, S.; Resteghini, C.; Galbiati, D.; Busico, A.; Paielli, N.; Patuzzo, R.; Maurichi, A.; Gallino, G.; Ruggeri, R.; Mariani, L.; Palla, M.; Licitra, L.; Bossi, P. Journal: European journal of cancer Issue: Volume 97(2018) Page Start: 7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. EP-1078: Nasopharyngeal Carcinoma: prognostic factors analysis in patients treated with IMRT and chemotherapy. (April 2016) Authors: Iacovelli, N.A.; Cavallo, A.; De Ponti, E.; Bossi, P.; Alfieri, S.; Rossi, G.; Naimo, S.; Bergamini, C.; Tana, S.; Licitra, L.; Pignoli, E.; Fallai, C.; Orlandi, E. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S518 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. EP-1080: Definitive or adjuvant IMRT for locally advanced sinonasal tumors: outcome and prognostic factors. (April 2016) Authors: Orlandi, E.; Cavallo, A.; De Ponti, E.; Iacovelli, N.A.; Bossi, P.; Nicolai, P.; Castelnuovo, P.; Guzzo, M.; Calareso, G.; Naimo, S.; Bergamini, C.; Locati, L.; Licitra, L.; Pignoli, E.; Fallai, C. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S519 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Management of tyrosine kinase inhibitors (TKI) side effects in differentiated and medullary thyroid cancer patients. Issue 3 (June 2017) Authors: Resteghini, C.; Cavalieri, S.; Galbiati, D.; Granata, R.; Alfieri, S.; Bergamini, C.; Bossi, P.; Licitra, L.; Locati, L.D. Journal: Best practice & research Issue: Volume 31:Issue 3(2017) Page Start: 349 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. MiR-494 induces metabolic reprogramming through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma. (March 2023) Authors: Galvani, G.; Leoni, I.; Bergamini, C.; Rizzardi, N.; Melli, M.; Coada, C.A.; Monti, E.; Giovannini, C.; Liparulo, I.; Ferracin, M.; Ravaioli, M.; Cescon, M.; Vasuri, F.; Piscaglia, F.; Negrini, M.; Stefanelli, C.; Fato, R.; Gramantieri, L.; Fornari, F. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗